DasarahallySMohanMD(He/Him)

Radiation Oncology • South San Francisco, CA

Radiation Oncologist, The Permanente Medical Group-NCaL

Join to view full profile

Dr. Mohan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mohan's full profile

Already have an account?

Office
1200 El Camino Real
South San Francisco, CA 94080
Phone+1 650-827-6500

Fax+1 510-625-6226

Education & Training

Cleveland Clinic FoundationResidency, Radiation Oncology, 1996 - 2000
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Radiation Oncology, 1996 - 1997
Brooklyn Hospital CenterInternship, Internal Medicine, 1995 - 1996
Bangalore Medical CollegeClass of 1986

Certifications & Licensure

CA State Medical License 2003 - 2026
UT State Medical License 2003 - 2006
OH State Medical License 2000 - 2000
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score Start of enrollment: 2021 Nov 03
Recruiting
Phase 3
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial Start of enrollment: 2020 Dec 15
Recruiting
Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer Start of enrollment: 2018 Oct 16
Recruiting
Phase 3

Publications & Presentations

PubMed

Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Andre Konski, Snehal Deshmukh, Ann H Klopp, Anamaria R Yeung, Shannon N Westin
Gynecologic Oncology. 2023-08-01
13 citations
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial.
Anamaria R Yeung, Snehal Deshmukh, Ann H Klopp, Karen M Gil, Lari Wenzel
Journal of Clinical Oncology. 2022-09-20
73 citations
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study
Anamaria R. Yeung, Stephanie L. Pugh, Ann H. Klopp, Karen M. Gil, Lari Wenzel
Journal of Clinical Oncology. 2020-02-19

Professional Memberships

ASTRO
Member